Do you want to read an article? Please log in or register.
Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Heart, Artery and Coronary Diseases
Related content
Heart, Artery and Coronary DiseasesTherapy and Intervention
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes
Eur J Cardiothorac Surg
Lansac E, Veen KM, Joseph A, Jaber PB, Sossi F, Das-Gupta Z, Aktaa S, Rafael Sádaba J, Thourani VH, Dahle G, Szeto WY, Bakaeen F, Aikawa E, Schoen FJ, Girdauskas E, Almeida A, Zuckermann A, Meuris B, Stott J, Kluin J, Meel R, Woan W, Colgan D, Jneid H, Balkhy H, Szerlip M, Preventza O, Shah P, Rigolin VH, Medica S, Holmes P, Sitges M, Pibarot P, Donal E, Hahn RT, Takkenberg JJM
doi: 10.1093/ejcts/ezae254
Heart, Artery and Coronary Diseases
Hospitalized upper extremity artery disease patients: treatment and long-term outcomes
Eur Heart J
Makowski L, Engelbertz C, Köppe J, Dröge P, Ruhnke T, Günster C, Gerß J, Freisinger E, Malyar N, Reinecke H, Feld J
doi: 10.1093/eurheartj/ehae904
RECOMMENDED
Cardiovascular Risk and Diseases
Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Am Heart J
Shah NP, Mulder H, Lydon B, Chiswell K, Hu X, Lampron Z, Cohen L, Patel MR, Taubes S, Song W, Mulukutla SR, Saeed A, Morin DP, Bradley SM, Hernandez AF, Pagidipati NJ
doi: 10.1016/j.ahj.2024.10.009
RECOMMENDED
Heart, Artery and Coronary DiseasesHypertension
Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Vrsalovic M, Heimark S, Søraas CL, Mehlum MH, Kjeldsen SE, Mancia G, Julius S, Weber MA
doi: 10.1161/HYPERTENSIONAHA.124.22832
Further Publications
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
JAMA Cardiol
Benziger CP, Stebbins A, Wruck LM, Effron MB, Marquis-Gravel G, Farrehi PM, Girotra S, Gupta K, Kripalani S, Munoz D, Polonsky TS, Sharlow A, Whittle J, Harrington RA, Rothman RL, Hernandez AF, Jones WS
doi: 10.1001/jamacardio.2024.1712
Cardiovascular Risk and Diseases
Five-Year Cumulative Cardiovascular Health and Clinical Events in Patients With Chronic Kidney Disease: The CRIC Study
J Am Heart Assoc
Cao Q, Bi Y, Alvarado F, Anderson AH, Mills KT, Jaeger BC, Chen J, He J, Bundy JD, CRIC Study Investigators *
doi: 10.1161/JAHA.123.033001
Cardiovascular Risk and Diseases
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
Eur Heart J
Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith AB, Dwight J, Ruciński M, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guðmundsdóttir IJ, Hrafnkelsdóttir ÞJ, Ingimarsdóttir IJ, Irs A, Jánosi A, Járai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP, Global Cardiovascular Outcomes Consortium and in collaboration with ACNAP, ACVC, EACVI, EAPC, EAPCI, EHRA, ESC Committee for Young CV Professionals, ESC Registry Committee, HFA, ESC Patient Forum and these Working Groups: aorta and peripheral vascular diseases, atherosclerosis and vascular biology, cardiac cellular electrophysiology, cardiovascular pharmacotherapy, cardiovascular regenerative and restorative medicine, cardiovascular surgery, cellular biology of the heart, e-cardiology, myocardial function, pulmonary circulation and right ventricular function and thrombosis
doi: 10.1093/eurheartj/ehae724
Cardiovascular Risk and Diseases
Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups
ESC 2024
Cardiovascular Risk and Diseases